Workflow
iHuman(IH)
icon
Search documents
iHuman(IH) - 2023 Q2 - Quarterly Report
2023-09-20 16:00
Financial Performance - Revenues for Q2 2023 were RMB241.0 million (US$33.2 million), a year-over-year increase of 4.5% from RMB230.6 million[2] - Gross profit was RMB170.8 million (US$23.6 million), reflecting a 4.7% increase from RMB163.2 million in the same period last year[6] - Operating income rose to RMB40.9 million (US$5.6 million), marking an 80.8% increase compared to RMB22.6 million in the same period last year[8] - Net income reached RMB42.1 million (US$5.8 million), a significant year-over-year increase of 93.1% from RMB21.8 million[9] - Adjusted net income for the three months ended June 30, 2023, was RMB 44,505,000, compared to RMB 23,822,000 for the same period in 2022, reflecting an increase of 86.7%[27] - The company reported a diluted net income per ADS of RMB 0.77 for the three months ended June 30, 2023, compared to RMB 0.40 for the same period in 2022, an increase of 92.5%[27] User Engagement - Average total MAUs for the quarter were 20.33 million, representing an 11.7% increase from 18.20 million in the same period last year[5] - The number of paying users was 1.31 million, contributing to the overall revenue growth[5] - The company launched new modules in its apps, including "Interactive Art Gallery" and "Chinese Characters in Daily Life," aimed at enhancing user engagement and creativity[3] Expenses and Cost Management - Research and development expenses decreased by 18.9% to RMB63.4 million (US$8.7 million) due to cost optimization efforts[7] Cash and Assets - Cash, cash equivalents, and time deposits increased to RMB1,104.8 million (US$152.4 million) as of June 30, 2023, compared to RMB1,050.0 million at the end of 2022[11] - Total assets increased from RMB 1,333,399,000 as of December 31, 2022, to RMB 1,341,907,000 as of June 30, 2023, reflecting a growth of 0.4%[20] - Total current assets rose from RMB 1,253,791,000 to RMB 1,273,298,000, an increase of 1.5%[20] - Cash and cash equivalents decreased from RMB 1,049,999,000 to RMB 967,472,000, a decline of 7.9%[20] Liabilities and Equity - Total liabilities decreased from RMB 563,947,000 to RMB 463,828,000, a reduction of 17.8%[20] - Total shareholders' equity increased from RMB 769,452,000 to RMB 878,079,000, a growth of 14.2%[21]
iHuman(IH) - 2022 Q4 - Annual Report
2023-04-24 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...
iHuman(IH) - 2022 Q4 - Annual Report
2023-04-24 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number: 001-39591 iHuman Inc. (Registrant's Name) Floor 8, Building B, No. 1 Wangjing East Road, Chaoyang District, Beijing 100102 People's Republic of China (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports ...
iHuman(IH) - 2023 Q1 - Quarterly Report
2023-03-30 16:00
Exhibit 99.1 1 iHuman Inc. Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results BEIJING, China, March 31, 2023 -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Highlights • Revenues reached a record-high of RMB260.7 million (US$37.8 million), compared with RMB237.8 million ...
iHuman(IH) - 2021 Q1 - Earnings Call Transcript
2021-06-08 17:18
iHuman Inc. (NYSE:IH) Q1 2021 Results Conference Call June 8, 2021 8:00 AM ET Company Participants Cynthia Tan - Senior IR Director Dr. Peng Dai - Director and Chief Executive Officer Vivian Wang - Director and Chief Financial Officer Conference Call Participants Mark Li - Citi Lauren Zuo - Credit Suisse Betty Zhou - Essence Securities Operator Good morning, and good evening, ladies and gentlemen. Thank you for standing by for iHuman's First Quarter 2021 Earnings Conference Call. At this time, all participa ...